QA: Vansen Pharma Inc in us_mining/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001378076_2013_Vansen_Pharma_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
warning Expenses in unusual place in relation to revenue input.sec.calculation_linkbase.edgar_model_mapping {'expenses_node': 'CostsAndExpenses', 'revenue_node': 'SalesRevenueNet', 'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}
info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.19871884789825595, 'aggregate_val': 102548, 'exp_sum': 85548, 'exp_to_value': {'GeneralAndAdministrativeExpense': 13336, 'CostOfRevenue': 0, 'DepreciationDepletionAndAmortization': 0, 'remainder_Expenses': 72212}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('EntityCommonStockSharesOutstanding')"}

Graph

Absolute values for 0001378076, Vansen Pharma Inc

  xvar xval
0 PropertyPlantAndEquipment 0
1 AssetsCurrent 15,015
2 AssetsNonCurrent 0
3 IntangibleAssets 0
4 remainder_Assets 0
5 LiabilitiesCurrent 119,478
6 LiabilitiesNonCurrent 0
7 remainder_Liabilities 0
8 GeneralAndAdministrativeExpense 13,336
9 CostOfRevenue 0
10 DepreciationDepletionAndAmortization 0
11 remainder_Expenses 89,212
12 remainder_Revenues 0
13 remainder_NetIncome -6,812
14 remainder_ComprehensiveNetIncome -1,852
  yvar yval
0 Assets 15,015
1 Liabilities 119,478
2 Expenses 102,548
3 Revenues 0
4 StockholdersEquity -104,463
5 NetIncome -109,360
6 ComprehensiveNetIncome -111,212
7 BaseVar 122,852
8 EconomicCapitalRatiobeforeLimitedLiability -3.98
9 EconomicCapitalRatio 0.0689

Edgar->Model Mapping

Feature Distribution

Change over Time